UEG press release

New study reveals 1 in 10 Inflammatory Bowel Disease patients are misdiagnosed with Irritable Bowel Syndrome

December 15, 2014

Dr Michael Scharl, IBS and IBD Expert

Study: 1 in 10 Inflammatory Bowel Disease patients are misdiagnosed with Irritable Bowel Syndrome.

(Vienna December, 15, 2014) A new study, published in the latest issue of the UEG Journal reveals that 10% of IBD patients are misdiagnosed with IBS and in 3% of cases the misdiagnosis can persist for five or more years. The case-controlled study, conducted in the UK, assessed the proportion of patients with IBS recorded prior to the IBD diagnosis to reveal the alarming statistics.

Leading IBD researcher and United European Gastroenterology (UEG) spokesperson Dr Michael Scharl says, “IBS has been estimated to affect at least 10% of the population in Europe and it causes distressing symptoms that disrupt normal life.” He explains, “We have known for some time that there are similarities between symptoms of IBS and IBD, but when it comes to diagnosis and treatment, this differs greatly.”

He adds, “Misdiagnosis is understandable as many symptoms such as diarrhoea, abdominal cramping and pain are common to both and the specific alarm symptoms for IBD such as bloody stool, weight loss or fever are often absent in IBD patients in the initial phase of their disease. However, increased use of faecal calprotectin testing would help doctors distinguish between inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis and non-inflammatory bowel diseases, such as irritable bowel syndrome.”

IBS has been estimated to affect at least 10 of the population in Europe. The initial misdiagnosis of IBD has serious consequences for patients, in particular those with Crohn's disease, since delays in diagnosis is correlated with an increased risk of bowel stenosis and CD-related intestinal surgery. Considering that the misdiagnosis of IBD might have severe consequences for a patient’s life, UEG are calling for increased efforts to be undertaken to screen symptomatic IBS patients for IBD. Screening tests for intestinal inflammation should be included in the work up of all new patients presenting with diarrhoea and pain.


1. Timothy R Card, Jesse Siffledeen and Kate M Fleming. Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database. 2: 505-512, UEG Journal December 2014. Available at: http://ueg.sagepub.com/content/2/6/505.full

Notes to Editors

About UEG

UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European societies concerned with digestive diseases. Together, its member societies represent over 22,000 specialists, working across medicine, surgery, paediatrics, gastrointestinal oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge. Find out more about UEG’s work. Visit www.ueg.eu

Available for interview

UEG Spokesperson, Dr Michael Scharl is an expert in both IBS and IBD and has recently been awarded a ‘UEG Rising Star’ award for his research which opens avenues for completely new treatment strategies for IBD and Crohn’s disease.

Press contact

Samantha Forster


Tel: +44 (0)1444 811099


Related Press Content

More Press releases